echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Teva Airduo ® Digihaler ™ inhaling powder gets FDA approval

    Teva Airduo ® Digihaler ™ inhaling powder gets FDA approval

    • Last Update: 2020-06-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    recently,pharmaceutical(http://giant Teva announced that the U.SFood andDrug(http://Authority (
    (http://) has approved airduo® Digihaler ™ (fluoroaticaso, 113 mcg/14 mcg) inhaled powder, which can be connected to a companion mobile app to provide information on the use of inhalers for asthma patientsAirduo® Digihaler ™ is the first digital-maintained asthma inhaler therapy with integrated sensors for
    people 12 years and older with(http://not suitable for relieving sudden breathing problems or replacing rescue inhalersAbout Airduo® The airduo™
    the Airduo® the ™ ™ the sensor, can detect when (http:// use the inhaler and measure the suction speed The data is then sent to a companion mobile app using Bluetooth wireless technology so that patients can view their treatment data at any time and share it with their medical (http:// health care provider if needed Patients can also arrange reminders on their smartphones and use Airduo ® Digihaler ™ treatment as required   The approval of Airduo® Digihaler ™ is based on the review of the supplementary New Drug (http:// Application (sNDA) submitted to the FDA by Tyva Airduo® Digihaler ™ combines a breath-driven multi-dose dry powder inhaler with fluoroteocason of propylene acid," in which fluorococinacinis is an inhaling corticosteroid (ICS) that helps reduce inflammation in the lungs, and Sametero is a long-acting beta-2 epinephrine-boosting (LABA) that helps the muscles around the airways of the lungs relax to prevent symptoms   Airduo ® Digihaler ™ approved for low, medium and high doses: 55/14 mcg, 113/14 mcg, 232/14 mcg, twice a day   As a fixed-dose combination asthma therapy with ICS and LABA, Airduo ® Digihaler ™ contain the same active ingredient as a dvair diskus ®, which is approved for low, medium and high doses: 100/50 mcg, 250/50 mcg, 500/50 mcg
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.